Export 54 results:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G. A, A, K., J, J., V, A., P, S., BP, D., B, K., and AG, K., Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease, Journal of neuroinflammation, vol. 9, 2012.
S. A, T, W., A, S., and AA, W., Neuroinflammation in Alzheimer's disease: Pleiotropic roles for cytokines and neuronal pentraxins.. 2018.
S. A.D., S., Z., E.M., P., Marti, M. E., S.K., M., and D.S., S., Oriented growth and transdifferentiation of mesenchymal stem cells towards a Schwann cell fate on micropatterned substrates, Journal of Bioscience and Bioengineering, In Press.
W. AA, N, M., and D, K., Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease., Diabetes, 2015.
W. AA, JL, W., MW, L., BB, B., AM, W., JM, O., A, R., RL, K., BP, H., NM, D., S, A., and SC, J., Family history and TOMM40 ‘523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts. 2017.
W. AA, BB, B., EJ, S., AC, B., SC, J., BT, C., OC, O., A, L. Rue, BP, H., RL, K., EM, J., MA, S., and S, A., Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease., JAMA Neurology, 2015.
W. AA, Does metabolic syndrome impact cognition and emotion in Alzheimer's disease?, European Journal of Neurology, 2016.
Y. M. Ambrosini, Borcherding, D., Kanthasamy, A., Kim, H. Jung, Willette, A. A., Jergens, A., Allenspach, K., and Mochel, J. P., The Gut-Brain-Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review.. In Press.
S. A† and AA†, W., Alzheimer’s Disease Neuroimaging Initiative. Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer's disease spectrum, Brain, Behavior, and Immunity, 2016.